US Bancorp DE Has $7.77 Million Position in Henry Schein, Inc. (HSIC)

Share on StockTwits

US Bancorp DE reduced its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 1.3% in the 3rd quarter, Holdings Channel reports. The firm owned 91,342 shares of the company’s stock after selling 1,186 shares during the period. US Bancorp DE’s holdings in Henry Schein were worth $7,768,000 as of its most recent filing with the SEC.

Other hedge funds have also modified their holdings of the company. NEXT Financial Group Inc acquired a new position in shares of Henry Schein during the third quarter worth approximately $103,000. McAdam LLC acquired a new position in shares of Henry Schein during the third quarter worth approximately $104,000. Squar Milner Financial Services LLC acquired a new position in shares of Henry Schein during the second quarter worth approximately $120,000. Piedmont Investment Advisors LLC acquired a new position in shares of Henry Schein during the second quarter worth approximately $130,000. Finally, Fuller & Thaler Asset Management Inc. lifted its holdings in shares of Henry Schein by 57.1% during the second quarter. Fuller & Thaler Asset Management Inc. now owns 2,200 shares of the company’s stock worth $160,000 after buying an additional 800 shares during the last quarter.

A number of research analysts have recently commented on the company. BidaskClub upgraded Henry Schein from a “hold” rating to a “buy” rating in a report on Wednesday, August 22nd. Robert W. Baird upped their price target on Henry Schein from $83.00 to $90.00 and gave the stock an “outperform” rating in a report on Tuesday, August 7th. Stifel Nicolaus upped their price target on Henry Schein from $76.00 to $81.00 and gave the stock a “hold” rating in a report on Tuesday, August 7th. Craig Hallum upped their price target on Henry Schein from $83.00 to $96.00 and gave the stock a “buy” rating in a report on Tuesday, August 7th. Finally, Zacks Investment Research lowered Henry Schein from a “buy” rating to a “hold” rating in a research note on Saturday, July 14th. Two investment analysts have rated the stock with a sell rating, nine have assigned a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the stock. Henry Schein currently has a consensus rating of “Hold” and a consensus target price of $84.41.

Shares of NASDAQ HSIC opened at $85.43 on Friday. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.30 and a quick ratio of 0.68. The firm has a market capitalization of $13.31 billion, a P/E ratio of 23.73, a PEG ratio of 2.71 and a beta of 0.87. Henry Schein, Inc. has a one year low of $62.56 and a one year high of $90.52.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Tuesday, November 6th. The company reported $1.03 earnings per share for the quarter, beating analysts’ consensus estimates of $1.01 by $0.02. Henry Schein had a return on equity of 20.40% and a net margin of 3.00%. The firm had revenue of $3.28 billion for the quarter, compared to analysts’ expectations of $3.37 billion. During the same period in the prior year, the business posted $0.87 earnings per share. The business’s revenue was up 3.8% compared to the same quarter last year. Equities analysts anticipate that Henry Schein, Inc. will post 4.12 EPS for the current year.

TRADEMARK VIOLATION WARNING: “US Bancorp DE Has $7.77 Million Position in Henry Schein, Inc. (HSIC)” was published by BBNS and is the property of of BBNS. If you are reading this piece on another website, it was illegally stolen and republished in violation of United States & international copyright & trademark legislation. The legal version of this piece can be accessed at https://baseballnewssource.com/2018/11/10/us-bancorp-de-has-7-77-million-position-in-henry-schein-inc-hsic/2972510.html.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Recommended Story: Understanding Compound Annual Growth Rate (CAGR)

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.